Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: Case-control analysis

Radiation Oncology

Volumn 4, Issue , 2009, Pages

  Alm el Din, Mohamed A ^a,b   Hughes, Kevin S ^a   Raad, Rita A ^a   Goldberg, Saveli I ^a   Aisenberg, Alan C ^a   Niemierko, Andrzej ^a   Taghian, Alphonse G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TANTA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINONE DERIVATIVE; BLEOMYCIN; CARBOPLATIN; CHLORAMBUCIL; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; HORMONE; IFOSFAMIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; BREAST TUMOR; CHILD; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION INJURY; RISK FACTOR; SECOND CANCER; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHILD; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68349123522     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-4-19     Document Type: Article

References (43)

1. Bhatia S Robison LL Oberlin O Greenberg M Bunin G Fossati-Bellani F Meadows AT Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 1996, 334:745-751. 10.1056/ NEJM199603213341201 8592547
2. Travis LB Curtis RE Boice JD Jr Late effects of treatment for childhood Hodgkin's disease N Engl J Med 1996, 335:352-353. 10.1056/ NEJM199608013350515 8668223
3. Hancock SL Tucker MA Hoppe RT Breast cancer after treatment of Hodgkin's disease J Natl Cancer Inst 1993, 85:25-31. 10.1093/jnci/85.1.25 8416252
4. Metayer C Lynch CF Clarke EA Glimelius B Storm H Pukkala E Joensuu T van Leeuwen FE van't Veer MB Curtis RE Holowaty EJ Andersson M Wiklund T Gospodarowicz M Travis LB Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence J Clin Oncol 2000, 18:2435-2443. 10856104
5. Ng AK Bernardo MV Weller E Backstrand K Silver B Marcus KC Tarbell NJ Stevenson MA Friedberg JW Mauch PM Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors Blood 2002, 100:1989-1996. 10.1182/ blood-2002-02-0634 12200357
6. Wahner-Roedler DL Nelson DF Croghan IT Achenbach SJ Crowson CS Hartmann LC O'Fallon WM Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience Mayo Clin Proc 2003, 78:708-715. 10.4065/78.6.708 12934780
7. Alm El-Din MA Hughes KS Finkelstein DM Betts KA Yock TI Tarbell NJ Aisenberg AC Taghian AG Breast cancer after treatment of Hodgkin's lymphoma: Risk factors that really matter Int J Radiat Oncol Biol Phys 2009, 73:69-74. 18538497
8. van Leeuwen FE Klokman WJ Veer MB Hagenbeek A Krol AD Vetter UA Schaapveld M van Heerde P Burgers JM Somers R Aleman BM Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood J Clin Oncol 2000, 18:487-497. 10653864
9. Tokunaga M Land CE Tokuoka S Nishimori I Soda M Akiba S Incidence of female breast cancer among atomic bomb survivors, 1950-1985 Radiat Res 1994, 138:209-223. 10.2307/3578591 8183991
10. Yahalom J Petrek JA Biddinger PW Kessler S Dershaw DD McCormick B Osborne MP Kinne DA Rosen PP Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients J Clin Oncol 1992, 10:1674-1681. 1403050
11. Meier P Kaplan EL Nonparametric estimation from incomplete observations Am Stat Assoc 1958, 53:457-481. 10.2307/2281868
12. Alm El-Din MA Feng JK Taghian AG Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma Nat Clin Pract Oncol 2008, 5:426-429. 10.1038/ ncponc1135 18493230
13. Wolden SL Hancock SL Carlson RW Goffinet DR Jeffrey SS Hoppe RT Management of breast cancer after Hodgkin's disease J Clin Oncol 2000, 18:765-772. 10673517
14. Dershaw DD Yahalom J Petrek JA Breast carcinoma in women previously treated for Hodgkin disease: Mammographic evaluation Radiology 1992, 184:421-423. 1320281
15. Gervais-Fagnou DD Girouard C Laperriere N Pintillie M Goss PE Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease Oncology 1999, 57:224-231. 10.1159/000012035 10545791
16. Chaudary MA Millis RR Hoskins EO Halder M Bulbrook RD Cuzick J Hayward JL Bilateral primary breast cancer: A prospective study of disease incidence Br J Surg 1984, 71:711-714. 10.1002/bjs.1800710924 6478165
17. Dixon JM Anderson TJ Page DL Lee D Duffy SW Stewart HJ Infiltrating lobular carcinoma of the breast: An evaluation of the incidence and consequence of bilateral disease Br J Surg 1983, 70:513-516. 10.1002/ bjs.1800700902 6311313
18. Hartman M Czene K Reilly M Bergh J Lagiou P Trichopoulos D Adami HO Hall P Genetic implications of bilateral breast cancer: A population based cohort study Lancet Oncol 2005, 6:377-382. 10.1016/S1470-2045(05)70174-1 15925815
19. Rosen PP Groshen S Kinne DW Hellman S Contralateral breast carcinoma: An assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up Surgery 1989, 106:904-910. 2814824
20. Cascinelli N Singletary E Greco M Ames F Testori A Baldini M Morabito A Bufalino R Shallenberger R Guinee V et al Long-term survival and prognostic factors for 2170 breast cancer patients treated at two cancer centers (Milan and Houston) Tumori 1989, 75:123-131. 2662539
21. de la Rochefordiere A Mouret-Fourme E Asselain B Scholl SM Campana F Broet P Fourquet A Metachronous contralateral breast cancer as first event of relapse Int J Radiat Oncol Biol Phys 1996, 36:615-621. 8948346
22. Hartman M Czene K Reilly M Adolfsson J Bergh J Adami HO Dickman PW Hall P Incidence and prognosis of synchronous and metachronous bilateral breast cancer J Clin Oncol 2007, 25:4210-4216. 10.1200/JCO.2006.10.5056 17878475
23. Robinson E Rennert G Rennert HS Neugut AI Survival of first and second primary breast cancer Cancer 1993, 71:172-176. 10.1002/ 1097-0142(19930101)71:1<172::AID-CNCR2820710127>3.0.CO;2-Y 8416714
24. Singletary SE Taylor SH Guinee VF Whitworth PW Jr Occurrence and prognosis of contralateral carcinoma of the breast J Am Coll Surg 1994, 178:390-396. 8149039
25. Janov AJ Tulecke M O'Neill A Lester S Mauch PM Harris J Schnitt SJ Shapiro CL Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: A case-control study Breast J 2001, 7:46-52. 10.1046/j.1524-4741.2001.007001046.x 11348415
26. Mauch PM Kalish LA Marcus KC Coleman CN Shulman LN Krill E Come S Silver B Canellos GP Tarbell NJ Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome Blood 1996, 87:3625-3632. 8611686
27. Lohrisch C Jackson J Jones A Mates D Olivotto IA Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer J Clin Oncol 2000, 18:2828-2835. 10920130
28. Zucali R Mariani L Marubini E Kenda R Lozza L Rilke F Veronesi U Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor J Clin Oncol 1998, 16:1363-1366. 9552038
29. Christie DR Wills R Drew JF Barton MB The doses received by the breast during mantle radiotherapy Int J Radiat Oncol Biol Phys 1998, 41:223-226. 9588937
30. Zellmer DL Wilson JF Janjan NA Dosimetry of the breast for determining carcinogenic risk in mantle irradiation Int J Radiat Oncol Biol Phys 1991, 21:1343-1351. 1938534
31. Baral NE Larsson LE Mattsson B Breast cancer following irradiation of the breast Cancer 1977, 40:2905-2910. 10.1002/ 1097-0142(197712)40:6<2905::AID-CNCR2820400621>3.0.CO;2-Y 589559
32. Boice JD Jr Radiation and breast carcinogenesis Med Pediatr Oncol 2001, 36:508-513. 10.1002/mpo.1122 11340604
33. Boice JD Jr Harvey EB Blettner M Stovall M Flannery JT Cancer in the contralateral breast after radiotherapy for breast cancer N Engl J Med 1992, 326:781-785. 1538720
34. Hildreth NG Shore RE Dvoretsky PM The risk of breast cancer after irradiation of the thymus in infancy N Engl J Med 1989, 321:1281-1284. 2797100
35. Little MP Boice JD Jr Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors Radiat Res 1999, 151:218-224. 10.2307/3579773 9952307
36. Preston DL Mattsson A Holmberg E Shore R Hildreth NG Boice JD Jr Radiation effects on breast cancer risk: A pooled analysis of eight cohorts Radiat Res 2002, 158:220-235. 10.1667/ 0033-7587(2002)158[0220:REOBCR]2.0.CO;2 12105993
37. Stovall M Smith SA Langholz BM Boice JD Jr Shore RE Andersson M Buchholz TA Capanu M Bernstein L Lynch CF Malone KE Anton-Culver H Haile RW Rosenstein BS Reiner AS Thomas DC Bernstein JL Women's Environmental, Cancer, and Radiation Epidemiology Study Collaborative Group Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study Int J Radiat Oncol Biol Phys 2008, 72:1021-1030. 18556141
38. Carter CL Allen C Henson DE Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Cancer 1989, 63:181-187. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H 2910416
39. Cutuli B Dhermain F Borel C de Larochefordiere A Graic Y de Lafontan B Dilhyudy JM Mignotte H Tessier E Tortochaux J N'Guyen T Bey P Le Mevel-Le Pourhiet A Velten M Arriagada R Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients Eur J Cancer 1997, 33:2315-2320. 10.1016/ S0959-8049(97)00235-9 9616274
40. Sanna G Lorizzo K Rotmensz N Bagnardi V Cinieri S Colleoni M Nole F Goldhirsch A Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors Ann Oncol 2007, 18:288-292. 10.1093/annonc/mdl399 17088328
41. Aref I Cross P Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease Br J Radiol 2000, 73:905-906. 11026871
42. Deutsch M Gerszten K Bloomer WD Avisar E Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma Am J Clin Oncol 2001, 24:33-34. 10.1097/ 00000421-200102000-00005 11232946
43. Intra M Gentilini O Veronesi P Ciocca M Luini A Lazzari R Soteldo J Farante G Orecchia R Veronesi U A new option for early breast cancer patients previously irradiated for Hodgkin's disease: Intraoperative radiotherapy with electrons (ELIOT) Breast Cancer Res 2005, 7:R828-832. 1242162 16168129 10.1186/bcr1310